Published in J Clin Microbiol on August 01, 1985
Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens. J Clin Microbiol (1990) 10.23
Rotavirus gene structure and function. Microbiol Rev (1989) 6.95
The rhesus rotavirus gene encoding protein VP3: location of amino acids involved in homologous and heterologous rotavirus neutralization and identification of a putative fusion region. Proc Natl Acad Sci U S A (1988) 4.23
Simple and specific enzyme immunoassay using monoclonal antibodies for serotyping human rotaviruses. J Clin Microbiol (1987) 3.54
Three-dimensional structure of rhesus rotavirus by cryoelectron microscopy and image reconstruction. J Cell Biol (1990) 2.83
Prediction of human rotavirus serotype by nucleotide sequence analysis of the VP7 protein gene. J Virol (1988) 2.44
Diversity of rotavirus serotypes in Mexican infants with gastroenteritis. J Clin Microbiol (1990) 1.85
Rotavirus serotypes 6 and 10 predominate in cattle. J Clin Microbiol (1990) 1.81
The rhesus rotavirus outer capsid protein VP4 functions as a hemagglutinin and is antigenically conserved when expressed by a baculovirus recombinant. J Virol (1989) 1.80
Temporal and geographical distributions of human rotavirus serotypes, 1983 to 1988. J Clin Microbiol (1989) 1.67
Murine rotavirus genes encoding outer capsid proteins VP4 and VP7 are not major determinants of host range restriction and virulence. J Virol (1993) 1.64
Identification of human and bovine rotavirus serotypes by polymerase chain reaction. Epidemiol Infect (1992) 1.62
Rotavirus epidemiology in Vellore, south India: group, subgroup, serotype, and electrophoretype. J Clin Microbiol (1988) 1.60
Relative frequencies of rotavirus serotypes 1, 2, 3, and 4 in Venezuelan infants with gastroenteritis. J Clin Microbiol (1988) 1.58
Subgroups, serotypes, and electrophoretypes of rotavirus isolated from children in Bangui, Central African Republic. J Clin Microbiol (1988) 1.54
Recovery from chronic rotavirus infection in mice with severe combined immunodeficiency: virus clearance mediated by adoptive transfer of immune CD8+ T lymphocytes. J Virol (1990) 1.51
Relative concentrations of serum neutralizing antibody to VP3 and VP7 proteins in adults infected with a human rotavirus. J Virol (1988) 1.49
Serologic analysis of human rotavirus serotypes P1A and P2 by using monoclonal antibodies. J Clin Microbiol (1993) 1.46
Amino acid substitution within the VP7 protein of G2 rotavirus strains associated with failure to serotype. J Clin Microbiol (2001) 1.44
Rotavirus capsid protein VP5* permeabilizes membranes. J Virol (1999) 1.42
Molecular and antigenic characterization of porcine rotavirus YM, a possible new rotavirus serotype. J Virol (1988) 1.38
Immunization with baculovirus-expressed VP4 protein passively protects against simian and murine rotavirus challenge. J Virol (1990) 1.37
Serotypic and genotypic characterization of human serotype 10 rotaviruses from asymptomatic neonates. J Clin Microbiol (1993) 1.36
Relation of VP7 amino acid sequence to monoclonal antibody neutralization of rotavirus and rotavirus monotype. J Virol (1991) 1.34
Rotavirus-specific cytotoxic T lymphocytes cross-react with target cells infected with different rotavirus serotypes. J Virol (1988) 1.25
Reactivities of serotyping monoclonal antibodies with culture-adapted human rotaviruses. J Clin Microbiol (1991) 1.22
Human viral gastroenteritis. Clin Microbiol Rev (1989) 1.21
Typing of human rotavirus VP4 by an enzyme immunoassay using monoclonal antibodies. J Clin Microbiol (1993) 1.19
Porcine rotaviruses antigenically related to human rotavirus serotypes 1 and 2. J Clin Microbiol (1990) 1.17
Direct identification of serotypes of natural human rotavirus isolates by hybridization using cDNA probes derived from segment 9 of the rotavirus genome. J Clin Microbiol (1989) 1.13
Murine intestinal antibody response to heterologous rotavirus infection. J Clin Microbiol (1991) 1.11
Dot hybridization assay for distinction of rotavirus serotypes. J Clin Microbiol (1989) 1.11
NS35 and not vp7 is the soluble rotavirus protein which binds to target cells. J Virol (1990) 1.08
Sequence analysis of gene 11 equivalents from "short" and "super short" strains of rotavirus. J Virol (1990) 1.08
Rotavirus serotype G9 strains belonging to VP7 gene phylogenetic sequence lineage 1 may be more suitable for serotype G9 vaccine candidates than those belonging to lineage 2 or 3. J Virol (2004) 1.06
Prevalent patterns of serotype-specific seroconversion in Mexican children infected with rotavirus. J Clin Microbiol (1987) 1.06
Comparative sensitivities of solid-phase immune electron microscopy and enzyme-linked immunosorbent assay for serotyping of human rotavirus strains with neutralizing monoclonal antibodies. J Clin Microbiol (1988) 1.05
Vaccinia virus recombinants expressing the SA11 rotavirus VP7 glycoprotein gene induce serotype-specific neutralizing antibodies. J Virol (1987) 1.05
Characterization of monoclonal antibodies to human group B rotavirus and their use in an antigen detection enzyme-linked immunosorbent assay. J Clin Microbiol (1989) 1.04
Genetic relatedness among human rotavirus genes coding for VP7, a major neutralization protein, and its application to serotype identification. J Clin Microbiol (1987) 1.03
Distribution of rotavirus VP7 serotypes and VP4 genotypes circulating in Sousse, Tunisia, from 1995 to 1999: emergence of natural human reassortants. J Clin Microbiol (2000) 0.99
Immunodominance of the VP4 neutralization protein of rotavirus in protective natural infections of young children. J Virol (1993) 0.99
Rotavirus diarrhea is caused by nonreplicating viral particles. J Virol (1995) 0.98
Serotypic analysis of VP3 and VP7 neutralization escape mutants of rhesus rotavirus. J Virol (1988) 0.96
VP4-specific intestinal antibody response to rotavirus in a murine model of heterotypic infection. J Virol (1991) 0.96
Comparisons of rotavirus VP7-typing monoclonal antibodies by competition binding assay. J Clin Microbiol (1992) 0.96
Antigenic and genomic diversity of human rotavirus VP4 in two consecutive epidemic seasons in Mexico. J Clin Microbiol (1998) 0.95
Persistence of intestinal antibody response to heterologous rotavirus infection in a murine model beyond 1 year. J Clin Microbiol (1993) 0.95
Comparison of enzyme immunoassay and reverse transcriptase PCR for identification of serotype G9 rotaviruses. J Clin Microbiol (1999) 0.94
Lack of cosegregation of the subgroup II antigens on genes 2 and 6 in porcine rotaviruses. J Virol (1990) 0.90
Rotavirus serotype G3 predominates in horses. J Clin Microbiol (1992) 0.90
Development and validation of DNA microarray for genotyping group A rotavirus VP4 (P[4], P[6], P[8], P[9], and P[14]) and VP7 (G1 to G6, G8 to G10, and G12) genes. J Clin Microbiol (2007) 0.87
Evaluation of three panels of monoclonal antibodies for the identification of human rotavirus VP7 serotype by ELISA. Bull World Health Organ (1990) 0.87
Evidence for two serotype G3 subtypes among equine rotaviruses. J Clin Microbiol (1992) 0.86
Serotype specificity of the neutralizing-antibody response induced by the individual surface proteins of rotavirus in natural infections of young children. Clin Diagn Lab Immunol (1998) 0.86
Phenotypic mixing during coinfection of cells with two strains of human rotavirus. J Virol (1988) 0.85
Homotypic and heterotypic serological responses to rotavirus neutralization epitopes in immunologically naive and experienced animals. J Clin Microbiol (1991) 0.84
Intestinal epithelia activate anti-viral signaling via intracellular sensing of rotavirus structural components. Mucosal Immunol (2010) 0.83
Antigenic and genetic characterization of serotype G2 human rotavirus strains from the African continent. J Clin Microbiol (2004) 0.82
The shift from low to high non-structural protein 1 expression in rotavirus-infected MA-104 cells. Mem Inst Oswaldo Cruz (2013) 0.77
Selection of cold-adapted mutants of human rotaviruses that exhibit various degrees of growth restriction in vitro. J Virol (1994) 0.75
Serotypic similarity and diversity of rotaviruses of mammalian and avian origin as studied by plaque-reduction neutralization. J Infect Dis (1984) 7.16
Genes of human (strain Wa) and bovine (strain UK) rotaviruses that code for neutralization and subgroup antigens. Virology (1981) 6.94
Serological analysis of the subgroup protein of rotavirus, using monoclonal antibodies. Infect Immun (1983) 5.85
Production and preliminary characterization of monoclonal antibodies directed at two surface proteins of rhesus rotavirus. J Virol (1983) 5.44
Rotaviruses: a review. Curr Top Microbiol Immunol (1983) 5.24
Identification of the rotaviral gene that codes for hemagglutination and protease-enhanced plaque formation. Virology (1983) 5.13
Direct isolation in cell culture of human rotaviruses and their characterization into four serotypes. J Clin Microbiol (1983) 4.88
Rescue of noncultivatable human rotavirus by gene reassortment during mixed infection with ts mutants of a cultivatable bovine rotavirus. Proc Natl Acad Sci U S A (1981) 4.47
Gene coding assignments for growth restriction, neutralization and subgroup specificities of the W and DS-1 strains of human rotavirus. J Gen Virol (1983) 4.25
Isolation of human rotavirus in cell cultures: brief report. Arch Virol (1981) 3.83
Sequential passages of human rotavirus in MA-104 cells. Microbiol Immunol (1981) 3.73
Comparison of direct electron microscopy, immune electron microscopy, and rotavirus enzyme-linked immunosorbent assay for detection of gastroenteritis viruses in children. J Clin Microbiol (1981) 3.05
Rotavirus isolation and cultivation in the presence of trypsin. J Clin Microbiol (1977) 2.99
Rescue and serotypic characterization of noncultivable human rotavirus by gene reassortment. Infect Immun (1982) 2.97
Reassortant rotaviruses as potential live rotavirus vaccine candidates. J Virol (1985) 2.95
Waterborne outbreak of rotavirus diarrhoea in adults in China caused by a novel rotavirus. Lancet (1984) 2.82
Serotyping and subgrouping of rotavirus strains by the ELISA test. Arch Virol (1982) 2.49
Rotavirus stability and inactivation. J Gen Virol (1979) 2.48
Preliminary characterization of an epitope involved in neutralization and cell attachment that is located on the major bovine rotavirus glycoprotein. J Virol (1985) 1.97
Infectious gastroenteritis in bone-marrow-transplant recipients. N Engl J Med (1982) 1.64
Hemagglutination by simian rotavirus. J Clin Microbiol (1978) 1.36
The influence of divalent cations on the stability of human rotavirus. Arch Virol (1981) 1.28
Rotavirus infection in a geriatric population. Arch Intern Med (1982) 1.28
Hemagglutination by human rotavirus strains. J Med Virol (1984) 1.09
Serological characterisation of human rotaviruses propagated in cell cultures. Brief report. Arch Virol (1984) 0.99
Plaque/focus immunoassay: a simple method for detecting antiviral monoclonal or other antibodies and viral antigens in cells. J Immunol Methods (1984) 0.93
Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein. J Virol (1992) 8.35
Serotypic similarity and diversity of rotaviruses of mammalian and avian origin as studied by plaque-reduction neutralization. J Infect Dis (1984) 7.16
Rotavirus gene structure and function. Microbiol Rev (1989) 6.95
Genes of human (strain Wa) and bovine (strain UK) rotaviruses that code for neutralization and subgroup antigens. Virology (1981) 6.94
X-ray crystallographic structure of the Norwalk virus capsid. Science (1999) 6.58
Sequence and genomic organization of Norwalk virus. Virology (1993) 6.25
Norwalk virus genome cloning and characterization. Science (1990) 5.83
Production and preliminary characterization of monoclonal antibodies directed at two surface proteins of rhesus rotavirus. J Virol (1983) 5.44
Rotaviruses: a review. Curr Top Microbiol Immunol (1983) 5.24
Human rotavirus type 2: cultivation in vitro. Science (1980) 5.22
Definition of human rotavirus serotypes by plaque reduction assay. Infect Immun (1982) 5.19
Enzyme-linked immunosorbent assay for detection of Escherichia coli heat-labile enterotoxin. J Clin Microbiol (1977) 5.17
Identification of the rotaviral gene that codes for hemagglutination and protease-enhanced plaque formation. Virology (1983) 5.13
Direct isolation in cell culture of human rotaviruses and their characterization into four serotypes. J Clin Microbiol (1983) 4.88
Proteolytic enhancement of rotavirus infectivity: molecular mechanisms. J Virol (1981) 4.87
Structural polypeptides of simian virus 40. J Virol (1971) 4.83
Epidemiology of human rotavirus Types 1 and 2 as studied by enzyme-linked immunosorbent assay. N Engl J Med (1978) 4.73
Direct serotyping of human rotavirus in stools by an enzyme-linked immunosorbent assay using serotype 1-, 2-, 3-, and 4-specific monoclonal antibodies to VP7. J Infect Dis (1987) 4.64
Epidemiology of Norwalk gastroenteritis and the role of Norwalk virus in outbreaks of acute nonbacterial gastroenteritis. Ann Intern Med (1982) 4.54
Rescue of noncultivatable human rotavirus by gene reassortment during mixed infection with ts mutants of a cultivatable bovine rotavirus. Proc Natl Acad Sci U S A (1981) 4.47
In vitro transcription and translation of simian rotavirus SA11 gene products. J Virol (1980) 4.40
Norwalk virus infection of volunteers: new insights based on improved assays. J Infect Dis (1994) 4.37
Gene coding assignments for growth restriction, neutralization and subgroup specificities of the W and DS-1 strains of human rotavirus. J Gen Virol (1983) 4.25
The rhesus rotavirus gene encoding protein VP3: location of amino acids involved in homologous and heterologous rotavirus neutralization and identification of a putative fusion region. Proc Natl Acad Sci U S A (1988) 4.23
Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses. J Virol (1994) 4.21
Age-dependent diarrhea induced by a rotaviral nonstructural glycoprotein. Science (1996) 4.08
Solid-phase microtiter radioimmunoassay for detection of the Norwalk strain of acute nonbacterial, epidemic gastroenteritis virus and its antibodies. J Med Virol (1978) 4.06
Structure of hepatitis B Dane particle DNA and nature of the endogenous DNA polymerase reaction. J Virol (1977) 4.02
Taxonomy of the caliciviruses. J Infect Dis (2000) 3.94
Antigenic characterization of human and animal rotaviruses by immune adherence hemagglutination assay (IAHA): evidence for distinctness of IAHA and neutralization antigens. Infect Immun (1981) 3.83
Detection of Norwalk virus in stool by polymerase chain reaction. J Clin Microbiol (1992) 3.82
Antigenic mapping of the surface proteins of rhesus rotavirus. Virology (1986) 3.80
Rotavirus infections in infants as protection against subsequent infections. N Engl J Med (1996) 3.61
Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers. Proc Natl Acad Sci U S A (1999) 3.30
Diagnosis of noncultivatable gastroenteritis viruses, the human caliciviruses. Clin Microbiol Rev (2001) 3.28
CCR6 mediates dendritic cell localization, lymphocyte homeostasis, and immune responses in mucosal tissue. Immunity (2000) 3.28
Use of transcription probes for genotyping rotavirus reassortants. Virology (1982) 3.23
Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to surface proteins vp3 and vp7. J Virol (1986) 3.17
Distinctive ribonucleic acid patterns of human rotavirus subgroups 1 and 2. Infect Immun (1981) 3.13
Molecular basis of rotavirus virulence: role of gene segment 4. J Virol (1986) 3.08
Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity. Science (1996) 3.07
Rescue and serotypic characterization of noncultivable human rotavirus by gene reassortment. Infect Immun (1982) 2.97
Reassortant rotaviruses containing structural proteins vp3 and vp7 from different parents induce antibodies protective against each parental serotype. J Virol (1986) 2.97
Norwalk virus open reading frame 3 encodes a minor structural protein. J Virol (2000) 2.96
Ultrastructural localization of rotavirus antigens using colloidal gold. Virus Res (1984) 2.95
Reassortant rotaviruses as potential live rotavirus vaccine candidates. J Virol (1985) 2.95
Three-dimensional structure of rhesus rotavirus by cryoelectron microscopy and image reconstruction. J Cell Biol (1990) 2.83
Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis. N Engl J Med (1976) 2.80
Detection of Norwalk virus in stool specimens by reverse transcriptase-polymerase chain reaction and nonradioactive oligoprobes. J Clin Microbiol (1992) 2.77
Localization of VP4 neutralization sites in rotavirus by three-dimensional cryo-electron microscopy. Nature (1990) 2.77
Detection of Norwalk virus and hepatitis A virus in shellfish tissues with the PCR. Appl Environ Microbiol (1995) 2.73
Infectious rotavirus enters cells by direct cell membrane penetration, not by endocytosis. J Virol (1988) 2.72
Microtiter solid-phase radioimmunoassay for detection of Escherichia coli heat-labile enterotoxin. Infect Immun (1977) 2.72
Correlation of patient immune responses with genetically characterized small round-structured viruses involved in outbreaks of nonbacterial acute gastroenteritis in the United States, 1990 to 1995. J Med Virol (1997) 2.70
Detection of enteric viruses in oysters by using the polymerase chain reaction. Appl Environ Microbiol (1993) 2.69
Identification, synthesis, and modifications of simian rotavirus SA11 polypeptides in infected cells. J Virol (1982) 2.67
A plaque assay for the simian rotavirus SAII. J Gen Virol (1979) 2.65
Multiple-challenge study of host susceptibility to Norwalk gastroenteritis in US adults. J Infect Dis (1990) 2.63
Three-dimensional visualization of mRNA release from actively transcribing rotavirus particles. Nat Struct Biol (1997) 2.63
Proteins of Norwalk virus. J Virol (1981) 2.59
Viral gastroenteritis. N Engl J Med (1991) 2.58
Comparison of the reactivities of baculovirus-expressed recombinant Norwalk virus capsid antigen with those of the native Norwalk virus antigen in serologic assays and some epidemiologic observations. J Clin Microbiol (1993) 2.58
Recombinant Norwalk virus-like particles given orally to volunteers: phase I study. Gastroenterology (1999) 2.54
Attachment and entry of recombinant Norwalk virus capsids to cultured human and animal cell lines. J Virol (1996) 2.51
Rotavirus stability and inactivation. J Gen Virol (1979) 2.48
Characterization of virus-like particles produced by the expression of rotavirus capsid proteins in insect cells. J Virol (1994) 2.48
Three-dimensional structure of baculovirus-expressed Norwalk virus capsids. J Virol (1994) 2.46
Visualization of ordered genomic RNA and localization of transcriptional complexes in rotavirus. Nature (1996) 2.45
CCR7 expression and memory T cell diversity in humans. J Immunol (2001) 2.42
The isolation and characterization of a Norwalk virus-specific cDNA. J Clin Invest (1991) 2.42
Approaches to immunization of infants and young children against gastroenteritis due to rotaviruses. Rev Infect Dis (1980) 2.39
Expression of rotavirus VP2 produces empty corelike particles. J Virol (1991) 2.38
Synthesis and immunogenicity of the rotavirus major capsid antigen using a baculovirus expression system. J Virol (1987) 2.29
Application of PCR to detect Norwalk virus in fecal specimens from outbreaks of gastroenteritis. J Clin Microbiol (1994) 2.27
Bonzo/CXCR6 expression defines type 1-polarized T-cell subsets with extralymphoid tissue homing potential. J Clin Invest (2001) 2.23
Structure and function of the polypeptides in simian virus 40. I. Existence of subviral deoxynucleoprotein complexes. J Virol (1972) 2.16
Detection and characterization of novel rotavirus strains in the United States. J Clin Microbiol (1998) 2.16
Environmental virology: from detection of virus in sewage and water by isolation to identification by molecular biology--a trip of over 50 years. Annu Rev Microbiol (1995) 2.13
Evaluation of a degenerate primer for the PCR detection of human caliciviruses. Arch Virol (1996) 2.11
Identification of the simian rotavirus SA11 genome segment 3 product. Virology (1988) 2.10
Receptor activity of rotavirus nonstructural glycoprotein NS28. J Virol (1989) 2.09
Functional and topographical analyses of epitopes on the hemagglutinin (VP4) of the simian rotavirus SA11. J Virol (1988) 2.08
Immune response and prevalence of antibody to Norwalk enteritis virus as determined by radioimmunoassay. J Clin Microbiol (1979) 2.06
Role of B cells and cytotoxic T lymphocytes in clearance of and immunity to rotavirus infection in mice. J Virol (1995) 2.06
Role of Norwalk virus in outbreaks of nonbacterial gastroenteritis. J Infect Dis (1979) 2.05
Comparison of mucosal and systemic humoral immune responses and subsequent protection in mice orally inoculated with a homologous or a heterologous rotavirus. J Virol (1994) 2.03
Human immune responses to a novel norwalk virus vaccine delivered in transgenic potatoes. J Infect Dis (2000) 2.02
Antigenic mapping of the recombinant Norwalk virus capsid protein using monoclonal antibodies. Virology (1996) 2.01
Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice. Proc Natl Acad Sci U S A (1996) 2.00
Antibodies to the trypsin cleavage peptide VP8 neutralize rotavirus by inhibiting binding of virions to target cells in culture. J Virol (1991) 1.99
Characterization of homotypic and heterotypic VP7 neutralization sites of rhesus rotavirus. Virology (1988) 1.98